Bcl-3 acts as an innate immune modulator by controlling antimicrobial responses in keratinocytes

Journal of Investigative Dermatology

Volumn 129, Issue 9, 2009, Pages 2148-2155

  Büchau, Amanda S ^a,b   MacLeod, Daniel T ^a   Morizane, Shin ^a   Kotol, Paul F ^a   Hata, Tissa ^a   Gallo, Richard L ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; COLECALCIFEROL; INTERLEUKIN 13; INTERLEUKIN 4; PROTEIN BCL 3; TUMOR NECROSIS FACTOR ALPHA;

ANTIMICROBIAL ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO CULTURE; INNATE IMMUNITY; KERATINOCYTE; PRIORITY JOURNAL; TH2 CELL;

AMINO ACID SEQUENCE; ANTIMICROBIAL CATIONIC PEPTIDES; CELLS, CULTURED; CHOLECALCIFEROL; DERMATITIS, ATOPIC; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-6; INTERLEUKIN-8; KERATINOCYTES; MOLECULAR SEQUENCE DATA; NF-KAPPA B P50 SUBUNIT; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS;

EID: 70349747079     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.49     Document Type: Article

References (37)

1. Bieber T (2008) Atopic Dermatitis. N Engl J Med 358:1483-1494
2. Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K et al. (1993) The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. Cell 72:729-739
3. Brasier AR, Lu M, Hai T, Lu Y, Boldogh I (2001) NF-kappa B-inducible BCL-3 expression is an autoregulatory loop controlling nuclear p50/NF-kappa B1 residence. J Biol Chem 276:32080-32093
4. Buchau AS, Schauber J, Hultsch T, Stuetz A, Gallo RL (2008) Pimecrolimus enhances TLR2/6-induced expression of antimicrobial peptides in keratinocytes. J Invest Dermatol 128:2646-2654
5. Carmody RJ, Ruan Q, Palmer S, Hilliard B, Chen YH (2007) Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitina-tion blockade. Science 317:675-678
6. Chen LF, Greene WC (2004) Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5:392-401
7. David M, Ford D, Bertoglio J, Maizel AL, Pierre J (2001) Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways. Oncogene 20:6660-6668
8. Elloumi HZ, Holland SM (2008) Complex regulation of human cathelicidin gene expression: novel splice variants and 50UTR negative regulatory element. Mol Immunol 45:204-217
9. Franzoso G, Bours V, Park S, Tomita-Yamaguchi M, Kelly K, Siebenlist U (1992) The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition. Nature 359:339-342
10. Fujita T, Nolan GP, Liou HC, Scott ML, Baltimore D (1993) The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. Genes Dev 7:1354-1363
11. Hata TR, Gallo RL (2008) Antimicrobial peptides, skin infections, and atopic dermatitis. Semin Cutan Med Surg 27:144-150
12. Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132:344-362
13. Howell MD, Boguniewicz M, Pastore S, Girolomoni G, Leung DY (2006a) Mechanism of HBD-3 deficiency in atopic dermatitis. Clin Immunol 121:332-338
14. Howell MD, Gallo RL, Boguniewicz M, Jones JF, Wong C, Streib JE et al. (2006b) Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 24:341-348
15. Howell MD, Novak N, Bieber T, Pastore S, Girolomoni G, Boguniewicz M et al. (2005) Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. J Invest Dermatol 125:738-745
16. Kolls JK, McCray PB Jr, Chan YR (2008) Cytokine-mediated regulation of antimicrobial proteins. Nat Rev Immunol 8:829-835
17. Kuwata H, Watanabe Y, Miyoshi H, Yamamoto M, Kaisho T, Takeda K et al. (2003) IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-alpha production in macrophages. Blood 102:4123-4129
18. Liu PT, Stenger S, Tang DH, Modlin RL (2007) Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 179:2060-2063
19. Massoumi R, Chmielarska K, Hennecke K, Pfeifer A, Fassler R (2006) Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling. Cell 125:665-677
20. McKeithan TW, Ohno H, Diaz MO (1990) Identification of a transcriptional unit adjacent to the breakpoint in the 14;19 translocation of chronic lymphocytic leukemia. Genes Chromosomes Cancer 1:247-255
21. Nishikori M, Maesako Y, Ueda C, Kurata M, Uchiyama T, Ohno H (2003) High-level expression of BCL3 differentiates t(2;5)(p23;q35)-positive anaplastic large cell lymphoma from Hodgkin disease. Blood 101:2789-2796
22. Ong PY, Hamid QA, Travers JB, Strickland I, Al Kerithy M, Boguniewicz M et al. (2002) Decreased IL-15 may contribute to elevated IgE and acute inflammation in atopic dermatitis. J Immunol 168:505-510
23. Rebollo A, Dumoutier L, Renauld JC, Zaballos A, Ayllon V, Martinez AC (2000) Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by AP1 and AP1-like transcription factors. Mol Cell Biol 20:3407-3416
24. Richard M, Louahed J, Demoulin JB, Renauld JC (1999) Interleukin-9 regulates NF-kappaB activity through BCL3 gene induction. Blood 93:4318-4327
25. Rocha S, Martin AM, Meek DW, Perkins ND (2003) p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1. Mol Cell Biol 23:4713-4727
26. Schauber J, Dorschner RA, Yamasaki K, Brouha B, Gallo RL (2006) Control of innate antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli. Immunol 118:509-519
27. Schauber J, Dorschner RA, Coda AB, Buchau AS, Liu PT, Kiken D et al. (2007) Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 117:803-811
28. Schauber J, Iffland K, Frisch S, Kudlich T, Schmausser B, Eck M et al. (2004) Histone-deacetylase inhibitors induce the expression of the cathelicidin LL-37 in human gastrointestinal cells. Mol Immunol 41:847-854
29. Schauber J, Svanholm C, Termen S, Iffland K, Menzel T, Scheppach W et al. (2003) Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut 52:735-741
30. Vita N, Lefort S, Laurent P, Caput D, Ferrara P (1995) Characterization and comparison of the interleukin 13 receptor with the interleukin 4 receptor on several cell types. J Biol Chem 270:3512-3517
31. Wang T-T, Nestel F, Bourdeau V, Nagai Y, Wang Q, Liao J et al. (2004) Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173:2909-2912
32. Westerheide SD, Mayo MW, Anest V, Hanson JL, Baldwin AS Jr (2001) The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G(1) transition. Mol Cell Biol 21:8428-8436
33. Xing N, Maldonado ML, Bachman LA, McKean DJ, Kumar R, Griffin MD (2002) Distinctive dendritic cell modulation by vitamin D(3) and glucocorticoid pathways. Biochem Biophys Res Commun 297:645-652
34. Yamasaki K, Di Nardo A, Bardan A, Murakami M, Ohtake T, Coda A et al. (2007) Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 13:975-980
35. Yu XP, Bellido T, Manolagas SC (1995) Down-regulation of NF-kappa B protein levels in activated human lymphocytes by 1,25-dihydroxyvita-min D3. Proc Natl Acad Sci USA 92:10990-10994
36. Zhang MY, Harhaj EW, Bell L, Sun SC, Miller BA (1998) Bcl-3 expression and nuclear translocation are induced by granulocyte-macrophage colony-stimulating factor and erythropoietin in proliferating human erythroid precursors. Blood 92:1225-1234
37. Zhang Q, Didonato JA, Karin M, McKeithan TW (1994) BCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteins. Mol Cell Biol 14:3915-3926